NCT05385991 Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally. Status COMPLETED Phase PHASE1
NCT05384561 Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19 Status RECRUITING Phase NA
NCT05367843 A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins Status TERMINATED Phase PHASE1
NCT05364268 Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation Status COMPLETED Phase N/A
NCT05364242 VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection Status COMPLETED Phase PHASE2/PHASE3
NCT05362682 Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique Status UNKNOWN Phase N/A
NCT05351437 To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19. Status COMPLETED Phase PHASE1
NCT05345873 A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years Status UNKNOWN Phase PHASE2
NCT05334134 COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children Status UNKNOWN Phase N/A
NCT05329051 A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years Status UNKNOWN Phase PHASE2
NCT05323461 A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines Status UNKNOWN Phase PHASE3
NCT05310084 Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age Status COMPLETED Phase PHASE3
NCT05308602 A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years Status WITHDRAWN Phase PHASE2
NCT05308576 A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05305547 A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 Status COMPLETED Phase PHASE3
NCT05290987 Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load. Status TERMINATED Phase NA